Search results
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 2 weeks agoUK-based pharmaceutical company GSK has reported updated results from a Phase II study of Jemperli...
FDA Prioritizes GSK's Breakthrough Drug Jemperli for Endometrial Cancer Treatment, a First in...
Benzinga via Yahoo Finance· 1 year agoThe FDA accepted the supplemental marketing application for GSK Plc's (NYSE: GSK) Jemperli...
GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial
Benzinga via Yahoo Finance· 2 years agoGSK plc (NYSE: GSK) announced results from the PERLA phase 2 trial investigating Jemperli...
Immunotherapy bowel cancer drug works for 100% of patients – researchers
Press Association News via AOL· 2 weeks agoJemperli – also called dostarlimab – from GSK showed ‘unprecedented results’, the firm said, with no...
New womb cancer treatment to benefit hundreds of patients each year
Press Association News via AOL· 3 months agoA drug which could buy women with advanced or recurring womb cancer more time with their loved ones...
Cancer disappears in 100% of patients treated with new drug in promising clinical trial
Euronews via Yahoo News· 3 days agoA study showed a 100 per cent positive response rate in 42 patients with a specific type of rectal...
Northwest Louisiana hospital participated in national research to treat endometrial cancer
Shreveport Times | The Times via Yahoo News· 1 year agoA northwest Louisiana hospital took part in groundbreaking research that could change how doctors...
Jemperli contends with blockbuster Keytruda in endometrial cancer
Clinical Trials Arena via Yahoo Finance· 1 month agoOn April 24, the FDA granted Priority Review to the supplemental Biologics License Application...
AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial
Benzinga via Yahoo Finance· 2 years agoAnaptysBio Inc (NASDAQ: ANAB) - GSK plc (NYSE: GSK) partnered PERLA head-to-head trial of Jemperli...
FDA Grants Complete Approval For GSK's Jemperli For Endometrial Cancer
Benzinga via Yahoo Finance· 1 year agoThe FDA has granted full approval to GSK plc's (NYSE: GSK) Jemperli (dostarlimab-gxly) for mismatch...